MUL1 抗体 (AA 45-95) (Cy7)
Quick Overview for MUL1 抗体 (AA 45-95) (Cy7) (ABIN1419740)
抗原
See all MUL1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 45-95
-
交叉反应
- 人, 小鼠, 大鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human MUL1/RNF218
-
亚型
- IgG
-
-
-
-
应用备注
-
FCM 1:20-100
IF(IHC-P) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- MUL1 (Mitochondrial E3 Ubiquitin Protein Ligase 1 (MUL1))
-
别名
- MUL1
-
背景
-
Synonyms: E3 ubiquitin-protein ligase MUL1, C1orf166, E3 ubiquitin ligase, E3 ubiquitin protein ligase MUL1, GIDE, Growth inhibition and death E3 ligase, MAPL, Mitochondrial anchored protein ligase, Mitochondrial ubiquitin ligase activator of NFKB 1, MUL1, MULAN, Putative NF kappa B activating protein 266, RING finger protein 218, RNF218, RP23-25C1.10-002, MUL1_HUMAN.
Background: E3 ubiquitin-protein ligase that plays a role in the control of mitochondrial morphology. Promotes mitochondrial fragmentation and influences mitochondrial localization. Inhibits cell growth. When overexpressed, activates JNK through MAP3K7/TAK1 and induces caspase-dependent apoptosis. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugatin.
-
基因ID
- 79594
-
UniProt
- Q969V5
-
途径
- Positive Regulation of Endopeptidase Activity
抗原
-